Novel furfurylidene N-acylhydrazones derived from natural safrole: discovery of LASSBio-1215, a new potent antiplatelet prototype

References

• Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269–1276.
   PubMed Web of Science ®Google Scholar
• Apostolakis S, Shantsila E, Lip GY. Evidence guided antiplatelet treatment: time to move from bench to bedside. Thromb Res 2009;124:649–650.
   PubMed Web of Science ®Google Scholar
• Shore-Lesserson L. Platelet inhibitors and monitoring platelet function: implications for bleeding. Hematol Oncol Clin North Am 2007;21:51–63.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Hamm CW. Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists. Lancet 2000;355:330–331.
   PubMed Web of Science ®Google Scholar
• Siddique A, Butt M, Shantsila E, Lip GY. New antiplatelet drugs: beyond aspirin and clopidogrel. Int J Clin Pract 2009;63:776–789.
   PubMed Web of Science ®Google Scholar
• Todeschini AR, Miranda ALP, Silva KCM, Parrini SC, Barreiro EJ. Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylaryl-hydrazone derivatives. Eur J Med Chem 1998;33:189–199.
   Web of Science ®Google Scholar
• Silva GA, Costa LM, Brito FC, Miranda AL, Barreiro EJ, Fraga CA. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives. Bioorg Med Chem 2004;12:3149–3158.
   PubMed Web of Science ®Google Scholar
• Brito FC, Kummerle AE, Lugnier C, Fraga CA, Barreiro EJ, Miranda AL. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition. Eur J Pharmacol 2010;638:5–12.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Serratos H, Chang R, Pereira EF, Castro NG, Aracava Y, Melo PA et al. A novel thienylhydrazone, (2-thienylidene)3,4-methylenedioxybenzoylhydrazine, increases inotropism and decreases fatigue of skeletal muscle. J Pharmacol Exp Ther 2001;299:558–566.
   PubMed Web of Science ®Google Scholar
• Silva AG, Zapata-Sudo G, Kummerle AE, Fraga CA, Barreiro EJ, Sudo RT. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues. Bioorg Med Chem 2005;13:3431–3437.
   PubMed Web of Science ®Google Scholar
• Kümmerle AE, Raimundo JM, Leal CM, da Silva GS, Balliano TL, Pereira MA et al. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives. Eur J Med Chem 2009;44:4004–4009.
   PubMed Web of Science ®Google Scholar
• Fraga CA, Barreiro EJ. Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Curr Med Chem 2006;13:167–198.
   PubMed Web of Science ®Google Scholar
• Rollas S, Küçükgüzel SG. Biological activities of hydrazone derivatives. Molecules 2007;12:1910–1939.
   PubMed Web of Science ®Google Scholar
• Duarte CD, Barreiro EJ, Fraga CA. Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem 2007;7:1108–1119.
   PubMed Web of Science ®Google Scholar
• Barreiro EJ, Fraga CAM. The utilization of the safrole, principal chemical constituent of sassafras oil, in the synthesis of compounds actives in the arachidonic acid cascade: antiinflammatory, analgesic and antithrombotic. Quim Nova 1999;22:744–759.
   Web of Science ®Google Scholar
• Lima PC, Lima LM, da Silva KC, Léda PH, de Miranda AL, Fraga CA et al. Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. Eur J Med Chem 2000;35:187–203.
   PubMed Web of Science ®Google Scholar
• Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178–195.
   PubMed Web of Science ®Google Scholar
• Jin J, Quinton TM, Zhang J, Rittenhouse SE, Kunapuli SP. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Blood 2002;99:193–198.
   PubMed Web of Science ®Google Scholar
• Chou TC, Li CY. Inhibitory mechanisms of dantrolene on platelet aggregation. Thromb Res 1999;96:299–307.
   PubMed Web of Science ®Google Scholar
• Pereira AS, Violante FA, Aquino-Neto FR, Cardoso JN, Fraga CAM, Barreiro EJ, Diastereomeric analysis of bioactive N-phenylpyrazole-4-acylhydrazone derivatives by high resolution gas chromatography. Anal Lett 1998;31:719–731.
   Web of Science ®Google Scholar
• Wavefunction Inc., Irvine, CA, 2000 (license number: DQAIR263775).
   Google Scholar
• Binkley JS, Pople JA, Hehre WJ. Self-consistent molecular orbital methods. 21. Small split-valence basis sets for first-row elements. J Am Chem Soc 1980;102:939–947.
   Web of Science ®Google Scholar
• Smith JB, Ingerman C, Kocsis JJ, Silver MJ. Formation of prostaglandins during the aggregation of human blood platelets. J Clin Invest 1973;52:965–969.
   PubMed Web of Science ®Google Scholar
• Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001;409:202–207.
   PubMed Web of Science ®Google Scholar